172 related articles for article (PubMed ID: 27566955)
1. Systems Pharmacogenomics Finds RUNX1 Is an Aspirin-Responsive Transcription Factor Linked to Cardiovascular Disease and Colon Cancer.
Voora D; Rao AK; Jalagadugula GS; Myers R; Harris E; Ortel TL; Ginsburg GS
EBioMedicine; 2016 Sep; 11():157-164. PubMed ID: 27566955
[TBL] [Abstract][Full Text] [Related]
2. Transcription Factor RUNX1 Regulates Platelet
Mao G; Songdej N; Voora D; Goldfinger LE; Del Carpio-Cano FE; Myers RA; Rao AK
Circulation; 2017 Sep; 136(10):927-939. PubMed ID: 28676520
[TBL] [Abstract][Full Text] [Related]
3. Regulation of platelet myosin light chain (MYL9) by RUNX1: implications for thrombocytopenia and platelet dysfunction in RUNX1 haplodeficiency.
Jalagadugula G; Mao G; Kaur G; Goldfinger LE; Dhanasekaran DN; Rao AK
Blood; 2010 Dec; 116(26):6037-45. PubMed ID: 20876458
[TBL] [Abstract][Full Text] [Related]
4. RUNX1 suppression induces megakaryocytic differentiation of UT-7/GM cells.
Nagai R; Matsuura E; Hoshika Y; Nakata E; Nagura H; Watanabe A; Komatsu N; Okada Y; Doi T
Biochem Biophys Res Commun; 2006 Jun; 345(1):78-84. PubMed ID: 16674921
[TBL] [Abstract][Full Text] [Related]
5. Unlocking Aspirin's Chemopreventive Activity: Role of Irreversibly Inhibiting Platelet Cyclooxygenase-1.
Lichtenberger LM; Fang D; Bick RJ; Poindexter BJ; Phan T; Bergeron AL; Pradhan S; Dial EJ; Vijayan KV
Cancer Prev Res (Phila); 2017 Feb; 10(2):142-152. PubMed ID: 27998883
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of TREM-like transcript-1 and collagen receptor α2 subunit, two novel RUNX1-targets, contributes to platelet dysfunction in familial platelet disorder with predisposition to acute myelogenous leukemia.
Glembotsky AC; Sliwa D; Bluteau D; Balayn N; Marin Oyarzún CP; Raimbault A; Bordas M; Droin N; Pirozhkova I; Washington V; Goette NP; Marta RF; Favier R; Raslova H; Heller PG
Haematologica; 2019 Jun; 104(6):1244-1255. PubMed ID: 30545930
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional Auto-Regulation of RUNX1 P1 Promoter.
Martinez M; Hinojosa M; Trombly D; Morin V; Stein J; Stein G; Javed A; Gutierrez SE
PLoS One; 2016; 11(2):e0149119. PubMed ID: 26901859
[TBL] [Abstract][Full Text] [Related]
8. The nonreceptor tyrosine kinase c-Abl phosphorylates Runx1 and regulates Runx1-mediated megakaryocyte maturation.
Liu H; Cui Y; Wang GF; Dong Q; Yao Y; Li P; Cao C; Liu X
Biochim Biophys Acta Mol Cell Res; 2018 Aug; 1865(8):1060-1072. PubMed ID: 29730354
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomics of platelet responsiveness to aspirin.
Faraday N; Becker DM; Becker LC
Pharmacogenomics; 2007 Oct; 8(10):1413-25. PubMed ID: 17979514
[TBL] [Abstract][Full Text] [Related]
10. Suppression of RUNX1 by siRNA in megakaryocytic UT-7/GM cells.
Okada Y; Nagai R; Matsuura E; Hoshika Y; Nakata E; Nagura H; Watanabe A; Komatsu N; Doi T
Nucleic Acids Symp Ser (Oxf); 2006; (50):261-2. PubMed ID: 17150917
[TBL] [Abstract][Full Text] [Related]
11. Aspirin and salicylic acid decrease c-Myc expression in cancer cells: a potential role in chemoprevention.
Ai G; Dachineni R; Muley P; Tummala H; Bhat GJ
Tumour Biol; 2016 Feb; 37(2):1727-38. PubMed ID: 26314861
[TBL] [Abstract][Full Text] [Related]
12. Aspirin effects on platelet gene expression are associated with a paradoxical, increase in platelet function.
Myers RA; Ortel TL; Waldrop A; Dave S; Ginsburg GS; Voora D
Br J Clin Pharmacol; 2022 May; 88(5):2074-2083. PubMed ID: 34705291
[TBL] [Abstract][Full Text] [Related]
13. Platelet protein kinase C-theta deficiency with human RUNX1 mutation: PRKCQ is a transcriptional target of RUNX1.
Jalagadugula G; Mao G; Kaur G; Dhanasekaran DN; Rao AK
Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):921-7. PubMed ID: 21252065
[TBL] [Abstract][Full Text] [Related]
14. Aspirin exposure reveals novel genes associated with platelet function and cardiovascular events.
Voora D; Cyr D; Lucas J; Chi JT; Dungan J; McCaffrey TA; Katz R; Newby LK; Kraus WE; Becker RC; Ortel TL; Ginsburg GS
J Am Coll Cardiol; 2013 Oct; 62(14):1267-1276. PubMed ID: 23831034
[TBL] [Abstract][Full Text] [Related]
15. Developmentally regulated promoter-switch transcriptionally controls Runx1 function during embryonic hematopoiesis.
Pozner A; Lotem J; Xiao C; Goldenberg D; Brenner O; Negreanu V; Levanon D; Groner Y
BMC Dev Biol; 2007 Jul; 7():84. PubMed ID: 17626615
[TBL] [Abstract][Full Text] [Related]
16. RUNX1-deficient human megakaryocytes demonstrate thrombopoietic and platelet half-life and functional defects.
Lee K; Ahn HS; Estevez B; Poncz M
Blood; 2023 Jan; 141(3):260-270. PubMed ID: 36219879
[TBL] [Abstract][Full Text] [Related]
17. Age-related promoter-switch regulates Runx1 expression in adult rat hearts.
Song J; Zhang X; Lv S; Liu M; Hua X; Yue L; Wang S; He W
BMC Cardiovasc Disord; 2023 Nov; 23(1):541. PubMed ID: 37936072
[TBL] [Abstract][Full Text] [Related]
18. RUNX1: an emerging therapeutic target for cardiovascular disease.
Riddell A; McBride M; Braun T; Nicklin SA; Cameron E; Loughrey CM; Martin TP
Cardiovasc Res; 2020 Jul; 116(8):1410-1423. PubMed ID: 32154891
[TBL] [Abstract][Full Text] [Related]
19. Salicylic acid metabolites and derivatives inhibit CDK activity: Novel insights into aspirin's chemopreventive effects against colorectal cancer.
Dachineni R; Kumar DR; Callegari E; Kesharwani SS; Sankaranarayanan R; Seefeldt T; Tummala H; Bhat GJ
Int J Oncol; 2017 Dec; 51(6):1661-1673. PubMed ID: 29075787
[TBL] [Abstract][Full Text] [Related]
20. Functional characterization of the promoter region of the human EVI1 gene in acute myeloid leukemia: RUNX1 and ELK1 directly regulate its transcription.
Maicas M; Vázquez I; Vicente C; García-Sánchez MA; Marcotegui N; Urquiza L; Calasanz MJ; Odero MD
Oncogene; 2013 Apr; 32(16):2069-78. PubMed ID: 22689058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
